Research suggests another side effect of weight loss drugs could be changing the brain - Scientists are looking to see how ...

The application of pharmacogenetics in identifying single nucleotide polymorphisms (SNPs) in DNA sequences that cause clinically significant alterations in drug-metabolizing enzyme activities is ...

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, compulsive thinking and emotional distress ...

Among the many ways neuroscientists think Alzheimer’s disease may strip away brain function is by disrupting the glucose metabolism needed to fuel the healthy brain. In essence, declining metabolism ...

This article is based on a poster originally authored by Daniel A. Barr, Mario Öeren, Peter A. Hunt, Jonathan D. Tyzack, Tomáš Chrien, Tamsin E. Mansley and Matthew D. Segall, which was presented at ...

Retatrutide altered circulating metabolites and lipids linked to fatty acid oxidation and insulin resistance in people with ...

A new study from Karolinska Institutet shows that different SSRI medications affect metabolic processes in developing nerve ...

An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a study published in Nature.

A new experimental obesity drug from Eli Lilly helped patients lose an average of about 85 pounds in a late-stage clinical ...